LAUREN BLITZER: Open Payments
NPI 1902409824 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 50 payments from 17 companies in 2025. Trend: 2023 $1,093 · 2024 $1,027 · 2025 $960
Food & beverage: $860Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $208 |
| Astellas Pharma US Inc | 3 | $147 |
| Lilly USA, LLC | 6 | $106 |
| Novo Nordisk Inc | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| PFIZER INC. | 3 | $62 |
| Amgen Inc. | 3 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $26 |
Products named: QULIPTA, AIRSUPRA, TRELEGY ELLIPTA, KISUNLA, EVENITY, UBRELVY, Veozah, PREVNAR 20.
Industry payments across AZ — which companies pay providers there.
